Ignite Creation Date:
2025-12-24 @ 10:19 PM
Ignite Modification Date:
2026-01-23 @ 2:50 PM
Study NCT ID:
NCT05409235
Status:
COMPLETED
Last Update Posted:
2024-08-09
First Post:
2022-06-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nesvategrast (OTT166) in Diabetic Retinopathy (DR)
Sponsor:
OcuTerra Therapeutics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Diabetic Retinopathy | View |